Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
Paul Thompson MD
Paul D. Thompson MD Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · October 28, 2021

Association of Hyper-Polypharmacy With Clinical Outcomes in HFpEF

Circulation: Heart Failure

 

 Save  Recommend
 Share

Additional Info

Circulation: Heart Failure
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
Circ Heart Fail 2021 Oct 22;[EPub Ahead of Print], M Minamisawa, B Claggett, K Suzuki, SM Hegde, AM Shah, AS Desai, EF Lewis, SJ Shah, NK Sweitzer, JC Fang, IS Anand, E O'Meara, JL Rouleau, B Pitt, MA Pfeffer, SD Solomon, O Vardeny

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated